Hysbysiad gwybodaeth ymlaen llaw
Hysbysiad gwybodaeth ymlaen llaw yn unig yw hwn
Adran I:
Endid
contractio
I.1) Enw a chyfeiriad
University Hospitals Birmingham NHS Foundation Trust
Mindelsohn Way
Birmingham
B15 2WB
UK
Person cyswllt: Matthew Kelsall
E-bost: matthew.kelsall@uhb.nhs.uk
NUTS: UKG3
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: https://www.uhb.nhs.uk/
Cyfeiriad proffil y prynwr: https://www.uhb.nhs.uk/
I.3) Cyfathrebu
Gellir cael gwybodaeth ychwanegol o'r cyfeiriad uchod
Mae cyfathrebu electronig yn gofyn am ddefnyddio offer a dyfeisiau nad ydynt ar gael yn gyffredinol. Mae mynediad uniongyrchol anghyfgyfyngiedig a llawn i'r offer a dyfeisiau hyn yn bosibl, yn rhad ac am ddim, yn:
https://health-family.force.com/s/Welcome
I.4) Y math o awdurdod contractio
Corff a lywodraethir gan gyfraith gyhoeddus
I.5) Prif weithgaredd
Iechyd
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
Systemic Anti-Cancer Therapy Electronic Prescribing System - Market Engagement
Cyfeirnod: PROC.08.0553
II.1.2) Prif god CPV
48180000
II.1.3) Y math o gontract
Cyflenwadau
II.1.4) Disgrifiad byr
University Hospitals Birmingham NHS Foundation Trust (the “Authority”) is conducting market engagement in relation to its requirement for a Electronic Prescribing solution for System Anti-Cancer Therapy (SACT).<br/><br/>University Hospitals Birmingham NHS Foundation Trust (“UHB”) is a large specialist teaching hospital that runs the Queen Elizabeth Hospital Birmingham (QEHB), Birmingham Chest Clinic, Heartlands Hospital (BHH), Good Hope Hospital (GHH), Solihull Hospital (SH) and various community services across the region.
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Na
II.2) Disgrifiad
II.2.2) Cod(au) CPV ychwanegol
48000000
II.2.3) Man cyflawni
Cod NUTS:
UKG3
II.2.4) Disgrifiad o’r caffaeliad
University Hospitals Birmingham NHS Foundation Trust (the “Authority”) is conducting market engagement in relation to its requirement for a Electronic Prescribing solution for System Anti-Cancer Therapy (SACT).<br/><br/>University Hospitals Birmingham NHS Foundation Trust (“UHB”) is a large specialist teaching hospital that runs the Queen Elizabeth Hospital Birmingham (QEHB), Birmingham Chest Clinic, Heartlands Hospital (BHH), Good Hope Hospital (GHH), Solihull Hospital (SH) and various community services across the region. <br/><br/>The Trust is looking to source a solution which replaces the current ways of working for prescribing systemic anti-cancer therapy (SACT) for patients attending its four hospital sites. The aim is to procure a designated SACT electronic prescribing system that will provide a robust, up to date and safe prescribing platform for patients requiring SACT and in doing so reduce prescribing errors, eradicate paper prescriptions, improve operational performance, improve patient safety and outcomes, and improve ways of working for staff.<br/><br/>Suppliers who are able to offer solutions relevant to this requirement are invited to express an interest and respond to a market engagement questionnaire. Further details on how to do this are contained within the additional information section of this notice.
II.3) Dyddiad amcangyfrifedig ar gyfer cyhoeddi’r hysbysiad contract:
01/01/2024
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Na
Section VI: Gwybodaeth ategol
VI.3) Gwybodaeth ychwanegol
Suppliers wishing to participate in this market engagement exercise and express an interest in this requirement should respond to the questionnaire via the online form on the Health Family Single eCommercial System Portal (Atamis) by 13:00 on Monday 30th October 2023.<br/><br/>https://atamis-1928.my.salesforce-sites.com/ProSpend__CS_ContractPage?SearchType=Projects&uid=a078d000004zElaAAE&searchStr=&sortStr=Recently+Published&page=1&filters=&County=
VI.5) Dyddiad anfon yr hysbysiad hwn
02/10/2023